Literature DB >> 20659889

Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells.

Priscilla Doyon1, Marc J Servant.   

Abstract

Activation of NF-κB transcription factors by locally produced angiotensin II (Ang II) is proposed to be involved in chronic inflammatory reactions leading to atherosclerosis development. However, a clear understanding of the signaling cascades coupling the Ang II AT1 receptors to the activation of NF-κB transcription factors is still lacking. Using primary cultured aortic vascular smooth muscle cells, we show that activation of the IKK complex and NF-κB transcription factors by Ang II is regulated by phosphorylation of the catalytic subunit IKKβ on serine residues 177 and 181 in the activation T-loop. The use of pharmacological inhibitors against conventional protein kinases C (PKCs), mitogen-activated/extracellular signal-regulated kinase (MEK) 1/2, ribosomal S6 kinase (RSK), and silencing RNA technology targeting PKCα, IKKβ subunit, tumor growth factor β-activating kinase-1 (TAK1), the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor-6 (TRAF6), and RSK isoforms, demonstrates the requirement of two distinct signaling pathway for the phosphorylation of IKKβ and the activation of the IKK complex by Ang II. Rapid phosphorylation of IKKβ requires a second messenger-dependent pathway composed of PKCα-TRAF6-TAK1, whereas sustained phosphorylation and activation of IKKβ requires the MEK1/2-ERK1/2-RSK pathway. Importantly, simultaneously targeting components of these two pathways completely blunts the phosphorylation of IKKβ and the proinflammatory effect of the octapeptide. This is the first report demonstrating activation of TAK1 by the AT1R. We propose a model whereby TRAF6-TAK1 and ERK-RSK intracellular pathways independently and sequentially converge to the T-loop phosphorylation for full activation of IKKβ, which is an essential step in the proinflammatory activity of Ang II.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659889      PMCID: PMC2945565          DOI: 10.1074/jbc.M110.126433

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

2.  Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors.

Authors:  Y Han; M S Runge; A R Brasier
Journal:  Circ Res       Date:  1999-04-02       Impact factor: 17.367

3.  Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.

Authors:  M Delhase; M Hayakawa; Y Chen; M Karin
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

4.  Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells.

Authors:  M J Servant; E Giasson; S Meloche
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

5.  Activation of IkappaB kinase beta by protein kinase C isoforms.

Authors:  M J Lallena; M T Diaz-Meco; G Bren; C V Payá; J Moscat
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 6.  Chemokines in the pathogenesis of vascular disease.

Authors:  Israel F Charo; Mark B Taubman
Journal:  Circ Res       Date:  2004-10-29       Impact factor: 17.367

Review 7.  Tissue renin-angiotensin systems. Their role in cardiovascular disease.

Authors:  M A Lee; M Böhm; M Paul; D Ganten
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

8.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Authors:  Lijun Sun; Li Deng; Chee-Kwee Ea; Zong-Ping Xia; Zhijian J Chen
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

9.  Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.

Authors:  Claudia Monaco; Evangelos Andreakos; Serafim Kiriakidis; Claudia Mauri; Colin Bicknell; Brian Foxwell; Nicholas Cheshire; Ewa Paleolog; Marc Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

10.  Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions.

Authors:  Y Seino; U Ikeda; M Ikeda; K Yamamoto; Y Misawa; T Hasegawa; S Kano; K Shimada
Journal:  Cytokine       Date:  1994-01       Impact factor: 3.861

View more
  8 in total

1.  Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.

Authors:  Anthony J Valente; Tadashi Yoshida; Subramanyam N Murthy; Siva S V P Sakamuri; Masato Katsuyama; Robert A Clark; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

2.  Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions.

Authors:  Zifang Song; Rong Jin; Shiyong Yu; Anil Nanda; D Neil Granger; Guohong Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-13       Impact factor: 8.311

3.  β-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells.

Authors:  Ricardo Charles; Yoon Namkung; Mathieu Cotton; Stéphane A Laporte; Audrey Claing
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

Review 4.  Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension.

Authors:  Olena Rudyk; Philip I Aaronson
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Systemic sclerosis immunoglobulin induces growth and a pro-fibrotic state in vascular smooth muscle cells through the epidermal growth factor receptor.

Authors:  Monique R Arts; Murray Baron; Nidaa Chokr; Marvin J Fritzler; Marc J Servant
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

6.  G protein-coupled receptors directly bind filamin A with high affinity and promote filamin phosphorylation.

Authors:  Kalyan C Tirupula; Sujay S Ithychanda; Maradumane L Mohan; Sathyamangla V Naga Prasad; Jun Qin; Sadashiva S Karnik
Journal:  Biochemistry       Date:  2015-11-02       Impact factor: 3.162

7.  Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II.

Authors:  Celeste Trejo-Moreno; Enrique Jiménez-Ferrer; Gabriela Castro-Martínez; Marisol Méndez-Martínez; María Angélica Santana; Gerardo Arrellín-Rosas; José Pedraza-Chaverri; Omar Noel Medina-Campos; Beatriz Hernández-Téllez; Oscar Ramírez-Pliego; Maribel Herrera-Ruiz; Jacquelynne Cervantes-Torres; Zimri Aziel Alvarado-Ojeda; Alejandro Costet-Mejía; Gladis Fragoso; Gabriela Rosas-Salgado
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

8.  The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation.

Authors:  Ugo Moens; Sergiy Kostenko; Baldur Sveinbjørnsson
Journal:  Genes (Basel)       Date:  2013-03-26       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.